Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|May 15, 2014
Evidence toward a dual phosphatase mechanism that restricts Aurora A (Thr-295) phosphorylation during the early embryonic cell cycleQing Kang, Jeyaraman Srividhya, Joseph Ipe, et al.
Clinical Pharmacology and Therapeutics|July 27, 2021
Mapping the miRNA-mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in PharmacogenesNicholas R Powell, Harrison Zhao, Joseph Ipe, et al.
Clinical and Translational Science|June 1, 2022
MicroRNA sequencing in patients with coronary artery disease - considerations for use as biomarker for thrombotic riskChimnonso P Onuoha, Joseph Ipe, Edward Simpson, et al.
Cancer Reports (Hoboken, N.J.)|July 30, 2022
Quantification of spatial pharmacogene expression heterogeneity in breast tumorsNicholas R Powell, Rebecca M Silvola, John S Howard, et al.
Atherosclerosis|October 19, 2018
Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarctionSri H Kanuri, Joseph Ipe, Kameel Kassab, et al.
Clinical and Translational Science|January 15, 2021
Variability of Dosing and Number of Medications Needed to Achieve Adequate Sedation in Mechanically Ventilated Pediatric Intensive Care PatientsEmma M Tillman, Joseph Ipe, Kelly J Weaver, et al.
Frontiers in Genetics|July 3, 2018
PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target SitesJoseph Ipe, Kimberly S Collins, Yangyang Hao, et al.
Bioorganic & Medicinal Chemistry|September 21, 2016
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and βLi-Ming Zhao, Hai-Shan Jin, Jinzhong Liu, et al.
Clinical Pharmacology and Therapeutics|August 11, 2020
Circulating miRNAs as Biomarkers for CYP2B6 Enzyme ActivityJoseph Ipe, Rudong Li, Ingrid F Metzger, et al.
Nature Communications|March 17, 2023
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver diseaseNicholas R Powell, Tiebing Liang, Joseph Ipe, et al.
Pageof 2